MOLECULAR TEMPLATES
Molecular Templates is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.
MOLECULAR TEMPLATES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.mtem.com
Total Employee:
11+
Status:
Active
Contact:
5122332709
Email Addresses:
[email protected]
Total Funding:
298.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Microsoft Exchange Online
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-02 | Threshold Pharmaceuticals | Threshold Pharmaceuticals acquired by Molecular Templates | N/A |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Debt - Molecular Templates
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Molecular Templates
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - Molecular Templates
Longitude Capital
Longitude Capital investment in Post-IPO Equity - Molecular Templates
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Molecular Templates
CAM Capital
CAM Capital investment in Post-IPO Equity - Molecular Templates
Takeda
Takeda investment in Post-IPO Equity - Molecular Templates
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Molecular Templates
Sante Ventures
Sante Ventures investment in Series D - Molecular Templates
Aju IB Investment
Aju IB Investment investment in Series C - Molecular Templates
Official Site Inspections
http://www.mtem.com Semrush global rank: 2.39 M Semrush visits lastest month: 7.69 K
- Host name: 209.182.196.37
- IP address: 209.182.196.37
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Molecular Templates"
Investor Relations :: Molecular Templates, Inc. (MTEM)
Aug 14, 2024 Company Overview. Molecular Templates is focused on the discovery, development, and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other …See details»
Molecular Templates, Inc. (MTEM) Company Profile & Overview
5 days ago Company profile for Molecular Templates, Inc. (MTEM) with a description, list of executives, contact details and other key facts.See details»
Corporate Governance :: Molecular Templates, Inc. (MTEM)
She served as a director of TransCelerate Biopharma Inc., a non-profit organization of pharmaceutical companies until 2016 and currently serves as a member of the Board of …See details»
Molecular Templates, Inc. (MTEM) Company Profile & Overview
Dec 24, 2024 Ticker Symbol: MTEM: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001183765: CUSIP Number: 608550109: ISIN …See details»
MTEM - Molecular Templates, Inc. | Company Profile | OTC Markets
Nov 25, 2024 www.mtem.com (512) 869-1555. [email protected]. Business Description. Molecular Templates is developing novel therapies in oncology and other serious diseases …See details»
Molecular Templates Inc, MTEM:PKL profile - FT.com - Financial …
6 days ago Molecular Templates Inc (MTEM:PKL) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Molecular Templates Inc, MTEM:PKL summary - FT.com
6 days ago MTEM:PKL trading volume exceeds daily average by +15.24% Dec 24 2024 About the company Molecular Templates, Inc. is a clinical-stage biopharmaceutical company focused …See details»
Molecular Templates, Inc. (MTEM) Statistics & Valuation Metrics
Dec 24, 2024 Detailed statistics for Molecular Templates, Inc. (MTEM) stock, including valuation metrics, financial numbers, share information and more.See details»
Molecular Templates - Crunchbase Company Profile
Contact Email [email protected] Phone Number 5122332709 Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.See details»
Company Information :: Molecular Templates, Inc. (MTEM)
[email protected]. Company Locations. 9301 Amberglen Blvd, Suite 100 Austin, TX 78729 8900 Amberglen Blvd, Suite 300 Austin, TX 78729 180 Varick Street, Suite 510 New York, NY …See details»
MTEM’s Competitors, Revenue, Number of Employees, Funding
MTEM’s Profile, Revenue and Employees. MTEM is a Texas-based clinical-stage biopharmaceutical company that researches and develops novel therapies for the treatment of …See details»
Molecular Templates (MTEM) Financials - Stock Analysis
Detailed annual and quarterly income statement for Molecular Templates (MTEM). See many years of revenue, expenses and profits or losses.See details»
Molecular Templates, Inc. - MTEM STOCK NEWS - Stock Titan
Dec 19, 2024 Welcome to our dedicated page for Molecular Templates news (Ticker: MTEM), a resource for investors and traders seeking the latest updates and insights on Molecular …See details»
About :: Molecular Templates, Inc. (MTEM)
Creating Novel Therapies for Cancer and Other Serious Diseases. Molecular Templates is developing novel therapies in oncology and other serious diseases through its proprietary …See details»
Molecular Templates (MTEM) Earnings Date and Reports 2025
Dec 20, 2024 Get the Latest News and Ratings for MTEM and Related Stocks. Enter your email address below to receive the latest news and analysts' ratings for Molecular Templates and its …See details»
Mtem - Overview, News & Similar companies | ZoomInfo.com
Aug 2, 2023 Who is Mtem. We have a dream to make the city a smart city with smart infrastructure using indigenous resources. The vision is to use the existing talent in the city to …See details»
Molecular Templates, Inc. (MTEM) - Stock Analysis
Why Molecular Templates (MTEM) Stock Is Down 60%. Molecular Templates Inc (NASDAQ: MTEM) shares are trading lower by 60% to 13 cents during Friday’s session after the company …See details»
MTEM Limited - Crunchbase Company Profile & Funding
MTEM Ltd. developed and built systems to perform land and marine transient electromagnetic surveys that can identify hydrocarbons before drilling, thus reducing the risk of . drilling “dry” …See details»
MTEM Company Profile 2024: Valuation, Investors, Acquisition
When was MTEM founded? MTEM was founded in 2004. Where is MTEM headquartered? MTEM is headquartered in Edinburgh, United Kingdom. What industry is MTEM in? MTEM’s primary …See details»
Molecular Templates, Inc. (MTEM) Historical Stock Price Data
Dec 24, 2024 Get a complete stock price history for MTEM (Molecular Templates), starting from its first trading day. Includes open, high, low, close and volume.See details»